Molecular Signatures of Neurodegenerative Diseases Identified by Proteomic and Phosphoproteomic Analyses in Aging Mouse Brain
Molecular & Cellular Proteomics · 2024-09 · 23 (9) · 100819
DOI: 10.1016/j.mcpro.2024.100819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular & Cellular Proteomics, 2024-09. Verfasst von Rodrigo Mohallem und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA. Hauptthemen laut MEDLINE: Aging, Proteomics, Brain, Neurodegenerative Diseases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ralph W and Grace M Showalter Research Trust Fund, Indiana Clinical and Translational Sciences Institute.
Abstract (Originalsprache)
A central hallmark of neurodegenerative diseases is the irreversible accumulation of misfolded proteins in the brain by aberrant phosphorylation. Understanding the mechanisms underlying protein phosphorylation and its role in pathological protein aggregation within the context of aging is crucial for developing therapeutic strategies aimed at preventing or reversing such diseases. Here, we applied multi-protease digestion and quantitative mass spectrometry to compare and characterize dysregulated proteins and phosphosites in the mouse brain proteome using three different age groups: young-adult (3-4 months), middle-age (10 months), and old mice (19-21 months). Proteins associated with senescence, neurodegeneration, inflammation, cell cycle regulation, the p53 hallmark pathway, and cytokine signaling showed significant age-dependent changes in abundances and level of phosphorylation. Several proteins implicated in Alzheimer's disease (AD) and Parkinson's disease (PD) including tau (Mapt), Nefh, and Dpysl2 (also known as Crmp2) were hyperphosphorylated in old mice brain suggesting their susceptibility to the diseases. Cdk5 and Gsk3b, which are known to phosphorylate Dpysl2 at multiple specific sites, had also increased phosphorylation levels in old mice suggesting a potential crosstalk between them to contribute to AD. Hapln2, which promotes α-synuclein aggregation in patients with PD, was one of the proteins with highest abundance in old mice. CD9, which regulates senescence through the PI3K-AKT-mTOR-p53 signaling was upregulated in old mice and its regulation was correlated with the activation of phosphorylated AKT1. Overall, the findings identify a significant association between aging and the dysregulation of proteins involved in various pathways linked to neurodegenerative diseases with potential therapeutic implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA.
- Department of Speech, Language, and Hearing Sciences, Purdue University, West Lafayette, Indiana, USA.
- Department of Comparative Pathobiology, College of Veterinary Medicine, Purdue University, West Lafayette, Indiana, USA; Purdue Proteomics Facility, Bindley Bioscience Center, Purdue University, West Lafayette, Indiana,…
Förderung
- Ralph W and Grace M Showalter Research Trust Fund
- Indiana Clinical and Translational Sciences Institute
Zitieren
APA
Mohallem, R., Schaser, A. J., & Aryal, U. K. (2024). Molecular Signatures of Neurodegenerative Diseases Identified by Proteomic and Phosphoproteomic Analyses in Aging Mouse Brain. Molecular & Cellular Proteomics, 23(9), 100819. https://doi.org/10.1016/j.mcpro.2024.100819
Vancouver
Mohallem R, Schaser AJ, Aryal UK. Molecular Signatures of Neurodegenerative Diseases Identified by Proteomic and Phosphoproteomic Analyses in Aging Mouse Brain. Molecular & Cellular Proteomics. 2024;23(9):100819. doi:10.1016/j.mcpro.2024.100819
BibTeX
@article{Mohallem2024,
author = {Mohallem, Rodrigo and Schaser, Allison J and Aryal, Uma K},
title = {Molecular Signatures of Neurodegenerative Diseases Identified by Proteomic and Phosphoproteomic Analyses in Aging Mouse Brain},
journal = {Molecular & Cellular Proteomics},
year = {2024},
volume = {23},
number = {9},
pages = {100819},
doi = {10.1016/j.mcpro.2024.100819}
}
EUVIMED